Madrigal Pharmaceuticals (MDGL) Stock Chart & Stock Price History $322.32 +5.17 (+1.63%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Madrigal Pharmaceuticals Stock Price Performance 5 Day Performance+2.67%1 Month Performance-7.47%3 Month Performance+17.58%6 Month Performance+49.62%Year-To-Date Performance+4.46%1 Year Performance+36.24% Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address MDGL Stock Chart for Monday, April, 14, 2025 MDGL Chart by TradingViewRemove Ads Madrigal Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/11/2025$307.35$317.15+3.19%$324.14$304.06390,555 shs$7.00 billion04/10/2025$313.95$307.35-2.10%$313.00$294.00385,181 shs$6.79 billion04/09/2025$302.78$313.95+3.69%$333.32$289.99510,432 shs$6.93 billion04/09/2025$302.78$313.95+3.69%$333.32$289.99510,432 shs$6.93 billion04/08/2025$310.52$302.78-2.49%$325.81$300.22342,841 shs$6.69 billion04/08/2025$310.52$302.78-2.49%$325.81$300.22342,841 shs$6.69 billion04/07/2025$314.39$310.52-1.23%$321.59$290.50533,863 shs$6.86 billion04/04/2025$327.10$314.39-3.89%$325.09$309.00343,494 shs$6.94 billion04/03/2025$334.60$327.10-2.24%$335.29$320.00223,305 shs$7.22 billion04/02/2025$323.98$334.60+3.28%$341.91$318.32365,332 shs$7.39 billion Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/01/2025$331.23$323.98-2.19%$334.93$320.70331,086 shs$7.15 billion03/31/2025$327.87$331.23+1.02%$333.00$310.00324,680 shs$7.31 billion03/28/2025$337.27$327.87-2.79%$336.79$324.02195,806 shs$7.24 billion03/27/2025$333.82$337.27+1.03%$338.44$331.67124,777 shs$7.45 billion03/26/2025$343.29$333.82-2.76%$343.41$330.73302,109 shs$7.37 billion03/25/2025$346.40$343.29-0.90%$350.50$335.50208,558 shs$7.58 billion03/24/2025$341.62$346.40+1.40%$346.93$338.23192,588 shs$7.65 billion03/21/2025$335.13$341.62+1.94%$344.19$330.03271,750 shs$7.54 billion03/20/2025$340.77$335.13-1.66%$342.57$334.94163,656 shs$7.40 billion03/19/2025$338.54$340.77+0.66%$341.18$332.17369,103 shs$7.52 billion03/18/2025$342.44$338.54-1.14%$343.56$331.11167,836 shs$7.47 billion03/17/2025$348.35$342.44-1.70%$350.00$336.96291,826 shs$7.56 billion03/14/2025$323.02$348.35+7.84%$348.35$326.70382,054 shs$7.69 billion03/13/2025$327.31$323.02-1.31%$332.40$321.27485,517 shs$7.23 billion Related Companies Biogen Stock Chart United Therapeutics Stock Chart Incyte Stock Chart BioMarin Pharmaceutical Stock Chart Exelixis Stock Chart Neurocrine Biosciences Stock Chart Exact Sciences Stock Chart Halozyme Therapeutics Stock Chart Repligen Stock Chart Alkermes Stock Chart Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDGL) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDGL Stock Free MDGL Stock Alerts